Uri Yablonka's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 40,000 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Brainstorm Cell Therapeuti... | Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 40,000 | 48,464 (0%) | 0% | 0 | Common Stock | |
Brainstorm Cell Therapeuti... | Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 20,000 | 68,464 (0%) | 0% | 0 | Common Stock | |
Brainstorm Cell Therapeuti... | Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 109,426 | 126,969 (0%) | 0% | 0 | Common Stock | |
Brainstorm Cell Therapeuti... | Uri Yablonka | Director, EVP & Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 10,000 | 17,543 (0%) | 0% | 0 | Common Stock |